CRISPR Therapeutics (CRSP) Market Cap 2016–2026

As of October 29, 2026, CRISPR Therapeutics had a market cap of $5.245 billion, which increased by 0.29% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
CRISPR Therapeutics logo

CRISPR Therapeutics AG (CRSP)

🌍 Switzerland 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$5.245B ▲ 0.29%
Start of 2026
$4.998B ▲ 4.94%
1 Year Ago
$5.735B ▼ 8.54%
All-Time High
$15.524B ▼ 66.21%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 CRISPR Therapeutics Market Cap History by Year and Month

CRISPR Therapeutics Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$5.245B▲ 4.94%
$5.245B▼ 1.91%
$5.347B▼ 2.92%
$5.508B▲ 19.07%
$4.626B▼ 12.00%
$5.257B▼ 2.97%
$5.418B▲ 7.84%
$5.024B▲ 10.03%
$4.566B▼ 20.91%
$5.773B▲ 21.26%
$4.761B▼ 4.74%
2025$4.998B▲ 48.09%
2024$3.375B▼ 32.12%
2023$4.972B▲ 56.25%
2022$3.182B▼ 45.46%
All market cap values reflect closing prices for the period shown.

📊 CRISPR Therapeutics Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:

  1. $12.85B
  2. $11.13B
  3. $10.21B
  4. $10.15B
  5. $9.97B
  6. $9.61B
  7. $9.34B
  8. $9.07B
  9. $8.79B
  10. $8.54B
  11. $8.06B
  12. $7.35B
  13. $7.1B
  14. $6.41B
  15. $5.49B
  16. $5.37B
  17. $5.25B
  18. $3.43B
  19. $2.03B
  20. $1.65B

Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.